Search - tctmd.com

Displaying 81 - 100 of 112

Sort: Relevancy | Date

Presentation TCT 2014

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Yoshinobu Onuma

September 16, 2014

Presentation TCT 2014

Scaffolds vs Stents: Biomechanics and Vascular Responses

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Juan F. Granada

September 16, 2014

Presentation TCT 2014

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Stephen G. Ellis

September 16, 2014

Presentation TCT 2014

Comparison of Current-Generation Metallic DES with BMS and First-Generation DES: Pathologic Progress and Remaining Challenges

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Renu Virmani

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

Presentation TCT 2014

Case #2: A Patient Who Might Especially Benefit from the COBRA PzF-Shielded Stent

Presenter: Renu Virmani

September 13, 2014

Presentation TCT 2014

The Concept of the COBRA PzF-Shielded Stent

Presenter: Renu Virmani, Donald Cutlip

September 13, 2014

News Daily News

Un Stent Recubierto de una Malla resulta Seguro en Pacientes STEMI aunque el Riesgo de RLD, RVD es Mayor que con los SMD

July 08, 2014

News Daily News

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

July 08, 2014

News Daily News

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

April 14, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

News Daily News

Stent Malapposition Frequent, But Without Clinical Consequences

Jason Kahn

January 27, 2014

News Daily News

La Mala Aposición del Stent es algo Frecuente que No tiene Consecuencias Clínicas

Jason Kahn

January 27, 2014

Presentation TCT 2013

Vascular Responses of Contemporary Durable Polymer DES, Bioabsorbable Polymer DES, Polymer-free DES and Fully Bioresorbable Scaffolds: Can Meaningful Differences in Vascular...

Presenter: Renu Virmani

October 27, 2013

Presentation TCT 2013

Impact of Varying Injury Severity and Multiple Treatments on Arterial Histopathology Early After Paclitaxel Coated Balloon Treatment of the Iliofemoral Arteries of Domestic Swine

Presenter: Maxwell Afari, Armando Tellez, Seung-Jin Oh, Krzysztof Milewski, Piotr Buszman, Renu Virmani, Juan Granada, Greg Kaluza

January 31, 2013

News Daily News

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Jason Kahn

January 22, 2013

Presentation TCT 2012

Paclitaxel Delivery and Tissue Effects: Similarities and Critical Differences with DES

Presenter: Renu Virmani

October 25, 2012

Presentation TCT 2012

Vascular Healing and the Evolution of DES Technologies: Pathology Insights from Human Specimens

Presenter: Renu Virmani

October 23, 2012

News Daily News

Los Balones liberadores de Fármacos arrojan Resultados Positivos en el Tratamiento de la Reestenosis intra stent

Jason Kahn

October 05, 2012

News Daily News

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Jason Kahn

October 05, 2012

Advertisement

Scaffolds vs Stents: 5-Year Insights from Longitudinal Imaging Studies

Scaffolds vs Stents: Biomechanics and Vascular Responses

The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data

Comparison of Current-Generation Metallic DES with BMS and First-Generation DES: Pathologic Progress and Remaining Challenges

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Case #2: A Patient Who Might Especially Benefit from the COBRA PzF-Shielded Stent

The Concept of the COBRA PzF-Shielded Stent

Un Stent Recubierto de una Malla resulta Seguro en Pacientes STEMI aunque el Riesgo de RLD, RVD es Mayor que con los SMD

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Stent Malapposition Frequent, But Without Clinical Consequences

La Mala Aposición del Stent es algo Frecuente que No tiene Consecuencias Clínicas

Vascular Responses of Contemporary Durable Polymer DES, Bioabsorbable Polymer DES, Polymer-free DES and Fully Bioresorbable Scaffolds: Can Meaningful Differences in Vascular...

Impact of Varying Injury Severity and Multiple Treatments on Arterial Histopathology Early After Paclitaxel Coated Balloon Treatment of the Iliofemoral Arteries of Domestic Swine

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Paclitaxel Delivery and Tissue Effects: Similarities and Critical Differences with DES

Vascular Healing and the Evolution of DES Technologies: Pathology Insights from Human Specimens

Los Balones liberadores de Fármacos arrojan Resultados Positivos en el Tratamiento de la Reestenosis intra stent

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content